Home > Healthcare > Drug Device Combination > Therapeutic Systems > Androgenetic Alopecia Treatment Market

Androgenetic Alopecia Treatment Market Share

Report ID: GMI9219
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Androgenetic Alopecia Treatment Market Share

The androgenetic alopecia treatment industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel treatment types with improved efficiency and cost-effectiveness are key market strategies for market players, driving competition and innovation in the industry. This emphasis on innovation aims to address evolving clinical needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for advanced androgenetic alopecia treatment.

Androgenetic Alopecia Treatment Companies

Some of the eminent market participants operating in the androgenetic alopecia treatment industry include:

Apira Science, Inc. (iGROW Laser)
Aurobindo Pharma
Cipla, Inc.
Curallux, LLC
Dr. Reddy’s Laboratories Ltd.
Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
Johnson & Johnson Services, Inc.
Lexington Intl., LLC
Merck & Co., Inc.
Theradome Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Androgenetic alopecia treatment market size was valued at USD 2.8 billion in 2023 and is estimated to grow at 7.6% CAGR from 2024 to 2032, driven by changing lifestyle patterns and genetic predisposition.

The pharmaceutical treatment type segment reached USD 1.4 billion in 2023 and will grow rapidly till 2032, owing to its effectiveness in slowing down hair loss.

North America androgenetic alopecia treatment market accounted for USD 943 million in revenue in 2023 and will grow rapidly till 2032, driven by the growing awareness of androgenetic alopecia treatment options.

Apira Science, Inc. (iGROW Laser), Aurobindo Pharma, Cipla, Inc., Curallux, LLC, Dr. Reddy